UNSPSC 51111730: Azotomycin

This classification denotes an antineoplastic antibiotic with the molecular formula C17H23N7O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6TQY580E8M, chemically known as l-norleucine, 6-diazo-n-(6-diazo-n-l-gamma-glutamyl-5-oxo-l-norleucyl)-5-oxo- but generally known as azotomycin, which bears US NIH Compound Identifier 24281. Azotomycin most often comes in base and sodium forms. The term AZOTOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5).

UNSPSC 51111730 Azotomycin is a Commodity code, but the recent state and local solicitations tagged under it do not reflect azotomycin procurement—they cover naloxone and drug deactivation systems, generic pharmaceuticals, over-the-counter products, and medical/first aid supplies for emergency response and health systems. State and local governments are actively buying naloxone, pharmaceutical distribution services, and emergency medical consumables under this code classification, though the taxonomy label does not align with the actual work being solicited. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), municipalities (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The procurements range from direct purchase of naloxone units and drug deactivation systems to pharmaceutical supply agreements serving multiple state and local facilities through authorized wholesalers.

Recent solicitations show activity concentrated in Florida and Texas, with multistate cooperative purchasing reaching Oregon and beyond. Seminole County issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023 (note: date discrepancy in source), with an estimated two-year initial term and one-year renewal option. The City of Tampa issued IFB 26P00145 on March 25, 2026, for medical and first aid supplies for the Tampa Fire Department Rescue Division—169 line items including respiratory equipment, cardiac monitoring electrodes, and consumables—with a response deadline of March 13, 2026 and an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount (not to exceed $10,000). Minnesota's MMCAP issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026, and awarded vendors effective July 1, 2026. Texas HHS Commission posted an exploratory Request for Information (HHS0017013) on April 3, 2026, to assess vendor capabilities for direct-to-manufacturer prescription fulfillment programs outside traditional pharmacy benefit manager arrangements.